Skip to main content

Advertisement

Log in

Reply to: “Ketorolac Following Mastectomy: Is There an Increased Risk of Reoperation?”

  • Breast Oncology
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

    We’re sorry, something doesn't seem to be working properly.

    Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Li L, Zhao X, Xiang B, Tang X. Ketorolac following mastectomy: is there an increased risk of reoperation? Ann Surg Oncol. 2021. https://doi.org/10.1245/s10434-021-10071-5.

  2. McCormick PJ, Assel M, Van Zee KJ, et al. Intraoperative ketorolac is associated with risk of reoperation after mastectomy: a single-center examination. Ann Surg Oncol. 2021. https://doi.org/10.1245/s10434-021-09722-4.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Patrick J. McCormick MD, MEng.

Ethics declarations

Disclosure

Patrick McCormick - Dr McCormick’s spouse holds stock in Johnson & Johnson. Monica Morrow - Honoraria (Roche)

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

McCormick, P.J., Assel, M., Van Zee, K.J. et al. Reply to: “Ketorolac Following Mastectomy: Is There an Increased Risk of Reoperation?”. Ann Surg Oncol 28 (Suppl 3), 777–778 (2021). https://doi.org/10.1245/s10434-021-10073-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-021-10073-3

Navigation